Literature DB >> 20052588

Response evaluation in head and neck oncology.

Robert Mandic, Jochen A Werner.   

Abstract

Mesh：

Year:  2010        PMID： 20052588     DOI： 10.1007/s00405-009-1192-4

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN： 0937-4477            Impact factor:   2.503


× No keyword cloud information.
  6 in total

Review 1.  Chemosensitivity and chemoresistance testing in ovarian cancer.

Authors:  Ian A Cree
Journal:  Curr Opin Obstet Gynecol       Date:  2009-02       Impact factor: 1.927

2.  Correlation of in vitro drug-sensitivity testing results with response to chemotherapy and survival in extensive-stage small cell lung cancer: a prospective clinical trial.

Authors:  A F Gazdar; S M Steinberg; E K Russell; R I Linnoila; H K Oie; B C Ghosh; J D Cotelingam; B E Johnson; J D Minna; D C Ihde
Journal:  J Natl Cancer Inst       Date:  1990-01-17       Impact factor: 13.506

Review 3.  In vitro assay-assisted treatment selection for women with breast or ovarian cancer.

Authors:  J P Fruehauf
Journal:  Endocr Relat Cancer       Date:  2002-09       Impact factor: 5.678

4.  Assay-based response evaluation in head and neck oncology: requirements for better decision making.

Authors:  Andreas Dietz; Andreas Boehm; Iris-Susanne Horn; Pierre Kruber; Ingo Bechmann; Wojciech Golusinski; Dietger Niederwieser; Ralph Dollner; Torsten W Remmerbach; Christian Wittekind; Stephan Dietzsch; Guido Hildebrandt; Gunnar Wichmann
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-01-06       Impact factor: 2.503

Review 5.  Is there a role for chemosensitivity tests in head and neck cancer?

Authors:  R Dollner; C Granzow; J A Werner; A Dietz
Journal:  Onkologie       Date:  2004-06

6.  American Society of Clinical Oncology Technology Assessment: chemotherapy sensitivity and resistance assays.

Authors:  Deborah Schrag; Harinder S Garewal; Harold J Burstein; David J Samson; Daniel D Von Hoff; Mark R Somerfield
Journal:  J Clin Oncol       Date:  2004-08-02       Impact factor: 44.544
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.